Jason Gardner
2018 - Dianthus Therapeutics
In 2018, Jason Gardner earned a total compensation of $4.7M as President and Chief Executive Officer at Dianthus Therapeutics, a 692% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $250,000 |
|---|---|
| Option Awards | $4,039,458 |
| Salary | $460,000 |
| Total | $4,749,458 |
Gardner received $4M in option awards, accounting for 85% of the total pay in 2018.
Gardner also received $250K in non-equity incentive plan and $460K in salary.
Rankings
In 2018, Jason Gardner's compensation ranked 2,162nd out of 14,244 executives tracked by ExecPay. In other words, Gardner earned more than 84.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,162 out of 14,244 | 85th |
Division Manufacturing | 781 out of 5,765 | 87th |
Major group Chemicals And Allied Products | 260 out of 2,128 | 88th |
Industry group Drugs | 208 out of 1,817 | 89th |
Industry Pharmaceutical Preparations | 161 out of 1,391 | 88th |
Source: SEC filing on April 25, 2019.
Gardner's colleagues
We found two more compensation records of executives who worked with Jason Gardner at Dianthus Therapeutics in 2018.
News
Dianthus Therapeutics Former President, Chief Financial and Operating Officer Stephen Mahoney's 2023 pay jumps 48% to $1.7M
April 11, 2024
Dianthus Therapeutics CEO Jason Gardner's 2021 pay falls 28% to $2.2M
May 2, 2022
Marqeta CEO Jason Gardner's 2021 pay jumps 7,132% to $224M
April 25, 2022
Dianthus Therapeutics CEO Jason Gardner's 2020 pay jumps 88% to $3.1M
April 21, 2021
Dianthus Therapeutics CEO Jason Gardner's 2018 pay jumps 692% to $4.7M
April 25, 2019